RISPERIDONE
- Product NDC
- 68071-4618
- Requested package NDC
- 68071-4618-3
- 11-digit product format
- 680714618
- Labeler code
- 68071
- Product ID
- 68071-4618_1ab66f0e-a2a8-09b0-e063-6394a90aec7b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- RISPERIDONE
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- NuCare Pharmaceuticals,Inc.
- Application
- ANDA201003
- Marketing category
- ANDA
- Marketing start
- 2014-03-28
- Substance
- RISPERIDONE
- Active strength
- 2 mg/1
- Pharmacologic classes
- Atypical Antipsychotic [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Archive | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024-05-28 21:12 UTC · source 2024-05-28 | excluded package | package | 68071-4618 | 68071-4618-3 | I | Inactivated by FDA | excluded / ndc_excluded.zip | 8af77b9d5b6f… | d9bbb34c5368… | |
| 2024-05-15 03:39 UTC · source 2024-05-14 | excluded package | package | 68071-4618 | 68071-4618-3 | I | Inactivated by FDA | excluded / ndc_excluded.zip | 834df4deac94… | adcc014656a3… | |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded package | package | 68071-4618 | 68071-4618-3 | I | Inactivated by FDA | excluded / ndc_excluded.zip | 1332a3947898… | d4bfe170f9cd… |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A201003-001 | RISPERIDONE | RISPERIDONE | 0.25MG | TABLET / ORAL | AB | 2011-08-24 | |
| A201003-002 | RISPERIDONE | RISPERIDONE | 0.5MG | TABLET / ORAL | AB | 2011-08-24 | |
| A201003-003 | RISPERIDONE | RISPERIDONE | 1MG | TABLET / ORAL | AB | 2011-08-24 | |
| A201003-004 | RISPERIDONE | RISPERIDONE | 2MG | TABLET / ORAL | AB | 2011-08-24 | |
| A201003-005 | RISPERIDONE | RISPERIDONE | 3MG | TABLET / ORAL | AB | 2011-08-24 | |
| A201003-006 | RISPERIDONE | RISPERIDONE | 4MG | TABLET / ORAL | AB | 2011-08-24 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A201003-001 | AB |
| A201003-002 | AB |
| A201003-003 | AB |
| A201003-004 | AB |
| A201003-005 | AB |
| A201003-006 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | A201003-001 | RISPERIDONE | 0.25MG | TABLET / ORAL | AB | 2011-08-24 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | A201003-002 | RISPERIDONE | 0.5MG | TABLET / ORAL | AB | 2011-08-24 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | A201003-003 | RISPERIDONE | 1MG | TABLET / ORAL | AB | 2011-08-24 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | A201003-004 | RISPERIDONE | 2MG | TABLET / ORAL | AB | 2011-08-24 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | A201003-005 | RISPERIDONE | 3MG | TABLET / ORAL | AB | 2011-08-24 | d4dbc9d85df4… | |
| 2026-11-14 07:37:17 | 2026-10 | A201003-006 | RISPERIDONE | 4MG | TABLET / ORAL | AB | 2011-08-24 | d4dbc9d85df4… | |
| 2026-10-15 13:18:30 | 2026-09 | A201003-001 | RISPERIDONE | 0.25MG | TABLET / ORAL | AB | 2011-08-24 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | A201003-002 | RISPERIDONE | 0.5MG | TABLET / ORAL | AB | 2011-08-24 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | A201003-003 | RISPERIDONE | 1MG | TABLET / ORAL | AB | 2011-08-24 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | A201003-004 | RISPERIDONE | 2MG | TABLET / ORAL | AB | 2011-08-24 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | A201003-005 | RISPERIDONE | 3MG | TABLET / ORAL | AB | 2011-08-24 | c2088c7a36db… | |
| 2026-10-15 13:18:30 | 2026-09 | A201003-006 | RISPERIDONE | 4MG | TABLET / ORAL | AB | 2011-08-24 | c2088c7a36db… | |
| 2026-09-14 22:38:34 | 2026-08 | A201003-001 | RISPERIDONE | 0.25MG | TABLET / ORAL | AB | 2011-08-24 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A201003-002 | RISPERIDONE | 0.5MG | TABLET / ORAL | AB | 2011-08-24 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A201003-003 | RISPERIDONE | 1MG | TABLET / ORAL | AB | 2011-08-24 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A201003-004 | RISPERIDONE | 2MG | TABLET / ORAL | AB | 2011-08-24 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A201003-005 | RISPERIDONE | 3MG | TABLET / ORAL | AB | 2011-08-24 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A201003-006 | RISPERIDONE | 4MG | TABLET / ORAL | AB | 2011-08-24 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A201003-001 | RISPERIDONE | 0.25MG | TABLET / ORAL | AB | 2011-08-24 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A201003-002 | RISPERIDONE | 0.5MG | TABLET / ORAL | AB | 2011-08-24 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A201003-003 | RISPERIDONE | 1MG | TABLET / ORAL | AB | 2011-08-24 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A201003-004 | RISPERIDONE | 2MG | TABLET / ORAL | AB | 2011-08-24 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A201003-005 | RISPERIDONE | 3MG | TABLET / ORAL | AB | 2011-08-24 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A201003-006 | RISPERIDONE | 4MG | TABLET / ORAL | AB | 2011-08-24 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A201003-001 | RISPERIDONE | 0.25MG | TABLET / ORAL | AB | 2011-08-24 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A201003-002 | RISPERIDONE | 0.5MG | TABLET / ORAL | AB | 2011-08-24 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A201003-003 | RISPERIDONE | 1MG | TABLET / ORAL | AB | 2011-08-24 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A201003-004 | RISPERIDONE | 2MG | TABLET / ORAL | AB | 2011-08-24 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A201003-005 | RISPERIDONE | 3MG | TABLET / ORAL | AB | 2011-08-24 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A201003-006 | RISPERIDONE | 4MG | TABLET / ORAL | AB | 2011-08-24 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A201003-001 | RISPERIDONE | 0.25MG | TABLET / ORAL | AB | 2011-08-24 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A201003-002 | RISPERIDONE | 0.5MG | TABLET / ORAL | AB | 2011-08-24 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A201003-003 | RISPERIDONE | 1MG | TABLET / ORAL | AB | 2011-08-24 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A201003-004 | RISPERIDONE | 2MG | TABLET / ORAL | AB | 2011-08-24 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A201003-005 | RISPERIDONE | 3MG | TABLET / ORAL | AB | 2011-08-24 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A201003-006 | RISPERIDONE | 4MG | TABLET / ORAL | AB | 2011-08-24 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A201003-001 | RISPERIDONE | 0.25MG | TABLET / ORAL | AB | 2011-08-24 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A201003-002 | RISPERIDONE | 0.5MG | TABLET / ORAL | AB | 2011-08-24 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A201003-003 | RISPERIDONE | 1MG | TABLET / ORAL | AB | 2011-08-24 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A201003-004 | RISPERIDONE | 2MG | TABLET / ORAL | AB | 2011-08-24 | 6a471c1ec25d… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-11-14 07:37:17 | 2026-10 | A201003-001 | AB | 1 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | A201003-002 | AB | 1 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | A201003-003 | AB | 1 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | A201003-004 | AB | 1 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | A201003-005 | AB | 1 | d4dbc9d85df4… |
| 2026-11-14 07:37:17 | 2026-10 | A201003-006 | AB | 1 | d4dbc9d85df4… |
| 2026-10-15 13:18:30 | 2026-09 | A201003-001 | AB | 1 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | A201003-002 | AB | 1 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | A201003-003 | AB | 1 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | A201003-004 | AB | 1 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | A201003-005 | AB | 1 | c2088c7a36db… |
| 2026-10-15 13:18:30 | 2026-09 | A201003-006 | AB | 1 | c2088c7a36db… |
| 2026-09-14 22:38:34 | 2026-08 | A201003-001 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A201003-002 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A201003-003 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A201003-004 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A201003-005 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A201003-006 | AB | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A201003-001 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A201003-002 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A201003-003 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A201003-004 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A201003-005 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A201003-006 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A201003-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A201003-002 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A201003-003 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A201003-004 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A201003-005 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A201003-006 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A201003-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A201003-002 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A201003-003 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A201003-004 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A201003-005 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A201003-006 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A201003-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A201003-002 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A201003-003 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A201003-004 | AB | 1 | 6a471c1ec25d… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- RISPERIDONE
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| RISPERIDONE | 2 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| L6UH7ZF8HC | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 312831 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 79648a52-1364-c25b-e053-2a91aa0a8ea4 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 6ab2126a-0ca2-c16c-ab6d-b3a031ba7ac6 | Product name | 5 | 20250303 |
| 0efa9fd6-2fb6-4cd3-8b0f-2a2bf9c4a09e | Product name | 1 | 20250128 |
| e457a910-2c3a-4bfd-90b9-0310982c50dd | Product name | 1 | 20241218 |
| 42b1a2d5-888a-4386-ab9f-0979e0d7b4aa | Product name | 1 | 20231010 |
| 66685e90-862d-4873-a0c5-2be73b803c36 | Product name | 1 | 20230921 |
| 92d220a1-2a4c-4393-9080-7335ca8223cc | Product name | 1 | 20230823 |
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68071-4618-3 | RISPERIDONE | 30 in 1 BOTTLE | TABLET | 30 | 4 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 68071-4618 | RISPERIDONE TABLET [NUCARE PHARMACEUTICALS,INC.] | 4 | Current NDC, Legacy NDC, 1 package rows | 20240706_79648a52-1364-c25b-e053-2a91aa0a8ea4.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| RISPERIDONE | RISPERIDONE | Aphena Pharma Solutions - Tennessee, LLC | bda104ac-1eea-4a1a-836a-24bcc034b90f | 2022-11-09 | Boxed warning, Warnings, Adverse reactions | 201003 ANDA201003 |
| RISPERIDONE | RISPERIDONE | Proficient Rx LP | 2b9cce47-b8b3-4c9b-b26a-3d742a0db8e2 | 2022-10-01 | Boxed warning, Warnings, Adverse reactions | 201003 ANDA201003 |
| RISPERIDONE | RISPERIDONE | Proficient Rx LP | 088dc3dd-7740-471b-8c06-5a47900ae5b5 | 2022-10-01 | Boxed warning, Warnings, Adverse reactions | 201003 ANDA201003 |
| RISPERIDONE | RISPERIDONE | Proficient Rx LP | 1b5c9889-4dc3-48df-8629-4ac099e2b4c0 | 2022-10-01 | Boxed warning, Warnings, Adverse reactions | 201003 ANDA201003 |
| RISPERIDONE | RISPERIDONE | Proficient Rx LP | 394c7e27-52a2-4d4c-8c6e-fe37b03266ae | 2022-06-01 | Boxed warning, Warnings, Adverse reactions | 201003 ANDA201003 |
| RISPERIDONE | RISPERIDONE | Aphena Pharma Solutions - Tennessee, LLC | ac152803-d75f-4c3c-bc49-8663b21a3a82 | 2019-04-29 | Boxed warning, Warnings, Adverse reactions | 201003 ANDA201003 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 312831 | risperiDONE 2 MG Oral Tablet | PSN | 79648a52-1364-c25b-e053-2a91aa0a8ea4 | 4 |
| 312831 | risperidone 2 MG Oral Tablet | SCD | 79648a52-1364-c25b-e053-2a91aa0a8ea4 | 4 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 68071-4618-3 | 68071461803 | 30 TABLET in 1 BOTTLE (68071-4618-3) | 30 tablet | 2018-10-29 | 0000-00-00 | No | No | Current |